BPC-157 Supports Vascular and Neurological Repair One underappreciated hallmark of long COVID is endothelial dysfunction damage to the lining of blood vessels that impairs circulation, oxygenation, and tissue delivery.7 BPC-157 has demonstrated angiogenic (new blood vessel formation) effects in research models, upregulating VEGFR2 and promoting collateral circulation in ischemic tissue.8 This matters for two reasons: Cardiovascular symptoms (breathlessness, reduced exercise tolerance, tachycardia) may partly reflect impaired tissue oxygenation from vascular damage Neurological symptoms (brain fog, cognitive impairment) may similarly reflect reduced cerebral blood flow BPC-157's neuroprotective effects shown across models of traumatic brain injury, dopamine dysregulation, and serotonin syndrome also suggest value in supporting the neurotransmitter disruption many long COVID patients experience.9 BPC-157 Modulates Inflammation Without Immune Suppression This is critical
Weekly Wellness Health Tip Strength training and GLP-1s Scientific evidence on the importance of strength training for patients being treated with GLP-1s The effects of drug-induced weight loss on muscle tissue In recent years, a new category of drug known as incretins, more generally called GLP-1 receptor agonists, has revolutionized the treatment of obesity and type 2 diabetes by offering significant benefits in terms of weight loss and improved glycaemic control
Batch-tested, COA available, and designed for metabolic signaling research
It contains a peptide that spurs weight loss by decreasing inflammation and increasing nitric oxide, which signals your body to optimize its metabolic rate for increased fat burning
Procedures such as gastric bypass or sleeve gastrectomy produce substantial, sustained weight loss and metabolic improvements
We offer consultations with our qualified healthcare professionals who can determine if GLP-1 medications are right for you
